Canada Sets Jan 2019 Deadline For Mandatory Adoption Of MDSAP Within Medtech Framework
This article was originally published in SRA
Executive Summary
As of January 2017, medical device manufacturers selling their products in Canada will get two years to comply with the requirements of the Medical Device Single Audit Program. Specifically, after January 2019 MDSAP will become the sole mechanism to demonstrate compliance with Canadian quality management system requirements1.
You may also be interested in...
Canada's Switch From CMDCAS To MDSAP Went Off Without A Hitch – Despite 403 Firms Leaving The Market
It's been one full month since the Medical Device Single Audit Program officially replaced the traditional Canadian Medical Devices Conformity Assessment System (CMDCAS) audits, and Health Canada is claiming success. Although 403 device-makers withdrew from the Canadian market because of the switch to MDSAP, it's nothing to be concerned about, a Health Canada spokesperson says.
EMA To Update Active Substances Guide To Address Nitrosamine Contamination
The European Medicines Agency wants to make it clearer for drug sponsors what more they can do to address the presence of cancer-causing impurities in active substances, and how to deal with the issue in their regulatory submissions.
Austria Cannot Offer Short Timelines For Reviewing Clinical Trials Under CTIS
Austria may not be part of an important monkeypox clinical trial taking place in several European Economic Area countries, but discussions on the study made the Austrian regulator realize its limitations in undertaking fast-track evaluations under the EU Clinical Trial Regulation.